Also called: Sermorelin + GHRP (GHRP-2, GHRP-6, or Ipamorelin), Sermorelin + CJC-1295, Sermorelin & Ipamorelin Blend
Sermorelin is a small protein fragment that tells the body's master gland to release more growth hormone. It works like a messenger. It was once sold as a medicine for children and adults who did not make enough growth hormone. Today, some clinics offer it through a doctor, and some lab suppliers sell it for research only.
Sermorelin tells a part of the brain called the pituitary gland to let out growth hormone. Growth hormone helps with growth, strong muscles, good sleep, energy, and healing. Doctors used it to check and treat growth problems. Some adults use it hoping for better sleep, more energy, and a healthier body, but these uses are not well proven.
The strong science on Sermorelin is old and mostly about growth problems in children. We do not have big, careful studies showing it helps healthy people feel younger or stronger. It can cause side effects like soreness where the shot is given, headaches, or flushing. People should only use it with a real doctor's care, and research products sold online are not checked for safety or purity.
Benefits
The main themes across 47 research studies, in plain language.
Studies indicate potential increases in lean muscle mass, muscle strength, and overall tone, alongside reductions in body fat, particularly in the abdominal area.
Findings imply that stimulating natural growth factors may help maintain or improve bone mineral density, potentially reducing the risk of osteoporosis.
Clinical research supports the use of the compound for increasing growth velocity in children with specific hormone deficiencies.
Research suggests that the compound stimulates the pituitary gland to release the body's own growth hormone and IGF-1, often preserving natural rhythmic pulses rather than causing a constant flood.
Research confirms the compound's utility as a diagnostic agent to provoke the pituitary gland and assess growth hormone reserve or deficiency.
Research indicates that combining this agent with other peptides (like GHRPs) can trigger a significantly stronger release of growth hormones than using them alone.
Some studies, particularly in men, suggest an improvement in libido and general well-being as part of hormonal optimization.
Research suggests that stimulating natural release may preserve the body's feedback mechanisms, potentially lowering risks associated with synthetic hormone overdosing.
Evidence suggests the compound may accelerate the repair of tissues, including muscles and joints, and aid recovery from physical training or injury.
Some research points to a reduction in systemic inflammation, which may contribute to recovery and neuroprotection.
Preliminary research suggests the therapy may support immune health by stimulating the production of immune cells like T-cells and regulating system responses.
Mechanistic studies suggest the compound may help reduce excessive tissue fibrosis or scarring.
Some studies indicate that the therapy may help regulate blood sugar and improve insulin sensitivity, potentially supporting metabolic health.
Animal and mechanistic studies indicate potential protective effects on heart tissue, such as reducing scarring after damage.
Research suggests potential benefits for mental clarity, memory, and focus, possibly linked to improved oxygen delivery or neuroprotective hormone activity.
Studies suggest that restoring hormone levels to more youthful ranges may support general vitality, longevity, and healthy aging.
Evidence suggests that increased hormone levels may support skin elasticity, hydration, and thickness, as well as overall connective tissue health.
Research points to improvements in sleep quality, specifically enhancing deep (slow-wave) sleep cycles and nocturnal hormone release, which may aid physical and mental recovery.
Laboratory research suggests the compound may inhibit the growth of specific tumor cells, such as gliomas, though this is an emerging area of study.
User-reported outcomes and some studies suggest improvements in overall energy, stamina, and mood, potentially related to better sleep and metabolic function.
You just read the research on Sermorelin. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
1 reported routine — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Safety
Adverse effects reported in the research and by community use.
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Sermorelin is a synthetic analog of growth hormone releasing hormone comprising the biologically active N-terminal 1-29 fragment of GHRH. It stimulates the pituitary to release endogenous GH and is FDA-approved as a provocative (stimulation) diagnostic test for growth hormone deficiency, principally in children.
Evidence
Every claim above traces back to a source you can check — here are 12 of them.
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
Stimulatory effect of growth hormone-releasing hormone (GHRH(1-29)NH2) on the proliferation, VEGF and chromogranin A secretion by human neuroendocrine tumor cell line NCI-H727 in vitro.
Study of the activation mechanism of human GRF(1-29)NH2 on rat mast cell histamine release.
PubChem - Compound - Sermorelin
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
Determination That GEREF (Sermorelin Acetate) Injection, 0.5 Milligrams Base/Vial and 1.0 Milligrams Base/Vial, and GEREF (Sermorelin Acetate) Injection, 0.05 Milligrams Base/Amp, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency
Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-hour infusion of GRF 1-29 amide in man
The effects of intranasal insufflation of growth hormone releasing factor analogue GRF 1-29 NH2 on growth hormone secretion in children with short stature
Sermorelin - MeSH
Timeline
Key moments in Sermorelin’s research and regulatory timeline — sourced and dated.
News
Dated, sourced reporting that mentions Sermorelin.
Wondering how Sermorelin pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.